1º Dia - 24/03/23
2º Dia - 25/03/23

Candidiase de repetição e vaginose citolitica Voltar

Telma Maria Figueiredo Franco

MESA 2 - DIRETO AO PONTO: ATUALIZAÇÃO AFECÇÕES VAGINAIS - Adriana Lucena

Artigo Autor(es) Referência
Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis. Lírio Juliana, Giraldo Paulo César, Sarmento Ayane Cristine, Costa Ana Paula Ferreira, Cobucci Ricardo Ney, Saconato Humberto, Eleutério Júnior José, Gonçalves Ana Katherine Revista da Associacao Medica Brasileira (1992). 2022 Feb; 68(Feb):261-267. doi: 10.1590/1806-9282.20210916. pii: S0104-42302022000200261.
Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol. Lírio Juliana, Giraldo Paulo Cesar, Amaral Rose Luce, Sarmento Ayane Cristine Alves, Costa Ana Paula Ferreira, Gonçalves Ana Katherine BMJ open. 2019 May; 9(May):e027489. doi: 10.1136/bmjopen-2018-027489. pii: .
Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis. Neal Chemen M, Martens Mark G SAGE open medicine. 2022 ; 10():20503121221115201. doi: 10.1177/20503121221115201. pii: 20503121221115201.
Compliance with the Updated BASHH Recurrent Vulvovaginal Candidiasis Guidelines Improves Patient Outcomes. Brown Lottie, Chamula Mathilde, Weinberg Sharon, Jbueen Frakinda, Rautemaa-Richardson Riina Journal of fungi (Basel, Switzerland). 2022 Aug; 8(Aug):doi: 10.3390/jof8090924. pii: 924.
Evidence-based update on Australasian pharmaceutical prescribing approaches for recurrent vulvovaginal candidiasis. Bradfield Strydom Moira, Walpola Ramesh Lahiru, Khan Sohil, Ware Robert S, Tiralongo Evelin The Australian & New Zealand journal of obstetrics & gynaecology. 2021 Aug; 61(Aug):496-499. doi: 10.1111/ajo.13376. pii: .
Lived experience of medical management in recurrent vulvovaginal candidiasis: a qualitative study of an uncertain journey. Bradfield Strydom Moira, Walpola Ramesh L, McMillan Sara, Khan Sohil, Ware Robert S, Tiralongo Evelin BMC women's health. 2022 09; 22(09):384. doi: 10.1186/s12905-022-01973-x. pii: .
Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion. Donders Gilbert, Sziller István Oszkár, Paavonen Jorma, Hay Phillip, de Seta Francesco, Bohbot Jean Marc, Kotarski Jan, Vives Jordi Antoni, Szabo Bela, Cepuliené Ramona, Mendling Werner Frontiers in cellular and infection microbiology. 2022 ; 12():934353. doi: 10.3389/fcimb.2022.934353. pii: 934353.
New perspectives on the topical management of recurrent candidiasis. Ré Ana Carolina S, Martins Jayanaraian F, Cunha-Filho Marcílio, Gelfuso Guilherme M, Aires Carolina P, Gratieri Taís Drug delivery and translational research. 2021 Aug; 11(Aug):1568-1585. doi: 10.1007/s13346-021-00901-0. pii: .
Oteseconazole (VIVOJA) for prevention of recurrent vulvovaginal candidiasis. Vanreppelen Giel, Nysten Jana, Baldewijns Silke, Sillen Mart, Donders Gilbert, Van Dijck Patrick Trends in pharmacological sciences. 2022 Nov; doi: 10.1016/j.tips.2022.10.004. pii: S0165-6147(22)00230-9.
Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis. Sobel Jack D, Nyirjesy Paul Future microbiology. 2021 Nov; doi: 10.2217/fmb-2021-0173. pii: .
Phase 3 Study of the Safety and Efficacy of Oteseconazole in Treatment of Recurrent Vulvovaginal Candidiasis and Efficacy vs Fluconazole in Treatment of Acute Vulvovaginal Candidiasis Infections. Martens Mark G, Maximos Bassem, Degenhardt Thorsten, Person Karen, Curelop Stacey, Ghannoum Mahmoud, Flynt Amy, Brand Stephen R American journal of obstetrics and gynecology. 2022 Jul; doi: 10.1016/j.ajog.2022.07.023. pii: S0002-9378(22)00577-4.
Recurrent Vulvovaginal Candidiasis: An Immunological Perspective. Rosati Diletta, Bruno Mariolina, Jaeger Martin, Ten Oever Jaap, Netea Mihai G Microorganisms. 2020 Jan; 8(Jan):doi: 10.3390/microorganisms8020144. pii: E144.
Topical Treatment of Recurrent Vulvovaginal Candidiasis: An Expert Consensus. Phillips Nancy A, Bachmann Gloria, Haefner Hope, Martens Mark, Stockdale Colleen Women's health reports (New Rochelle, N.Y.). 2022 ; 3():38-42. doi: 10.1089/whr.2021.0065. pii: .
Treating (Recurrent) Vulvovaginal Candidiasis with Medical-Grade Honey-Concepts and Practical Considerations. van Riel Senna J J M, Lardenoije Celine M J G, Oudhuis Guy J, Cremers Niels A J Journal of fungi (Basel, Switzerland). 2021 Aug; 7(Aug):doi: 10.3390/jof7080664. pii: 664.
Treatment for recurrent vulvovaginal candidiasis (thrush). Cooke Georga, Watson Cathy, Deckx Laura, Pirotta Marie, Smith Jane, van Driel Mieke L The Cochrane database of systematic reviews. 2022 01; 1(01):CD009151. doi: 10.1002/14651858.CD009151.pub2. pii: .
Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp. Grant Leah M, Orenstein Robert Journal of investigative medicine high impact case reports. 10():23247096221123144. doi: 10.1177/23247096221123144. pii: .
Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence. Pereira Lívia Custódio, Correia Amabel Fernandes, da Silva Zita Dinis Lopes, de Resende Ceres Nunes, Brandão Fabiana, Almeida Rosane Mansan, de Medeiros Nóbrega Yanna Karla European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2021 Aug; 40(Aug):1681-1693. doi: 10.1007/s10096-021-04199-1. pii: .
Nenhuma revista foi definida para este congresso.